These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 25845525)
1. Increased expression of neuropilin 1 is associated with epithelial ovarian carcinoma. Jiang H; Xi Q; Wang F; Sun Z; Huang Z; Qi L Mol Med Rep; 2015 Aug; 12(2):2114-20. PubMed ID: 25845525 [TBL] [Abstract][Full Text] [Related]
2. Decreased semaphorin 3A expression is associated with a poor prognosis in patients with epithelial ovarian carcinoma. Jiang H; Qi L; Wang F; Sun Z; Huang Z; Xi Q Int J Mol Med; 2015 May; 35(5):1374-80. PubMed ID: 25812535 [TBL] [Abstract][Full Text] [Related]
3. Upregulation of centrosomal protein 55 is associated with unfavorable prognosis and tumor invasion in epithelial ovarian carcinoma. Zhang W; Niu C; He W; Hou T; Sun X; Xu L; Zhang Y Tumour Biol; 2016 May; 37(5):6239-54. PubMed ID: 26615423 [TBL] [Abstract][Full Text] [Related]
4. Formyl peptide receptor 2 expression predicts poor prognosis and promotes invasion and metastasis in epithelial ovarian cancer. Xie X; Yang M; Ding Y; Yu L; Chen J Oncol Rep; 2017 Dec; 38(6):3297-3308. PubMed ID: 29039544 [TBL] [Abstract][Full Text] [Related]
5. AEG -1 overexpression: a novel indicator for peritoneal dissemination and lymph node metastasis in epithelial ovarian cancers. Li C; Liu J; Lu R; Yu G; Wang X; Zhao Y; Song H; Lin P; Sun X; Yu X; Zhang Y; Ning X; Geng J Int J Gynecol Cancer; 2011 May; 21(4):602-8. PubMed ID: 21543927 [TBL] [Abstract][Full Text] [Related]
6. NRP1 is targeted by miR-130a and miR-130b, and is associated with multidrug resistance in epithelial ovarian cancer based on integrated gene network analysis. Chen C; Hu Y; Li L Mol Med Rep; 2016 Jan; 13(1):188-96. PubMed ID: 26573160 [TBL] [Abstract][Full Text] [Related]
7. Clinicopathological values of NBS1 and DNA damage response genes in epithelial ovarian cancers. Lee YK; Park NH; Lee H Exp Mol Med; 2015 Nov; 47(11):e195. PubMed ID: 26584681 [TBL] [Abstract][Full Text] [Related]
8. Upregulation of Abelson interactor protein 1 predicts tumor progression and poor outcome in epithelial ovarian cancer. Zhang J; Tang L; Chen Y; Duan Z; Xiao L; Li W; Liu X; Shen L Hum Pathol; 2015 Sep; 46(9):1331-40. PubMed ID: 26193797 [TBL] [Abstract][Full Text] [Related]
9. Neuropilin-1 expression in squamous cell carcinoma of the oesophagus. Alattar M; Omo A; Elsharawy M; Li J Eur J Cardiothorac Surg; 2014 Mar; 45(3):514-20. PubMed ID: 23956271 [TBL] [Abstract][Full Text] [Related]
10. Lewis(y) antigen promotes the progression of epithelial ovarian cancer by stimulating MUC1 expression. Hou R; Jiang L; Liu D; Lin B; Hu Z; Gao J; Zhang D; Zhang S; Iwamori M Int J Mol Med; 2017 Aug; 40(2):293-302. PubMed ID: 28586014 [TBL] [Abstract][Full Text] [Related]
11. The biphasic expression pattern of miR-200a and E-cadherin in epithelial ovarian cancer and its correlation with clinicopathological features. Xu S; Xu P; Wu W; Ou Y; Xu J; Zhang G; Li J; Xu G Curr Pharm Des; 2014; 20(11):1888-95. PubMed ID: 23888941 [TBL] [Abstract][Full Text] [Related]
12. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients. Tassi RA; Todeschini P; Siegel ER; Calza S; Cappella P; Ardighieri L; Cadei M; Bugatti M; Romani C; Bandiera E; Zanotti L; Tassone L; Guarino D; Santonocito C; Capoluongo ED; Beltrame L; Erba E; Marchini S; D'Incalci M; Donzelli C; Santin AD; Pecorelli S; Sartori E; Bignotti E; Odicino F; Ravaggi A J Exp Clin Cancer Res; 2017 May; 36(1):63. PubMed ID: 28482906 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA‑455 inhibits cell proliferation and invasion of epithelial ovarian cancer by directly targeting Notch1. Xu L; Li H; Su L; Lu Q; Liu Z Mol Med Rep; 2017 Dec; 16(6):9777-9785. PubMed ID: 29039517 [TBL] [Abstract][Full Text] [Related]
14. Sam68 is Overexpressed in Epithelial Ovarian Cancer and Promotes Tumor Cell Proliferation. Dong L; Che H; Li M; Li X Med Sci Monit; 2016 Sep; 22():3248-56. PubMed ID: 27623016 [TBL] [Abstract][Full Text] [Related]
15. Promoter Hypermethylation of FANCF and Susceptibility and Prognosis of Epithelial Ovarian Cancer. Ding JJ; Wang G; Shi WX; Zhou HH; Zhao EF Reprod Sci; 2016 Jan; 23(1):24-30. PubMed ID: 26507869 [TBL] [Abstract][Full Text] [Related]
16. MicroRNA-130b functions as a tumor suppressor by regulating RUNX3 in epithelial ovarian cancer. Paudel D; Zhou W; Ouyang Y; Dong S; Huang Q; Giri R; Wang J; Tong X Gene; 2016 Jul; 586(1):48-55. PubMed ID: 27048832 [TBL] [Abstract][Full Text] [Related]
17. Low levels of ADAM23 expression in epithelial ovarian cancer are associated with poor survival. Ma R; Tang Z; Sun K; Ye X; Cheng H; Chang X; Cui H Pathol Res Pract; 2018 Aug; 214(8):1115-1122. PubMed ID: 29921495 [TBL] [Abstract][Full Text] [Related]
18. Misregulation of polo-like protein kinase 1, P53 and P21WAF1 in epithelial ovarian cancer suggests poor prognosis. Zhang R; Shi H; Ren F; Liu H; Zhang M; Deng Y; Li X Oncol Rep; 2015 Mar; 33(3):1235-42. PubMed ID: 25592872 [TBL] [Abstract][Full Text] [Related]
19. MiR-135a functions as a tumor suppressor in epithelial ovarian cancer and regulates HOXA10 expression. Tang W; Jiang Y; Mu X; Xu L; Cheng W; Wang X Cell Signal; 2014 Jul; 26(7):1420-6. PubMed ID: 24607788 [TBL] [Abstract][Full Text] [Related]
20. Overexpression of PRMT5 promotes tumor cell growth and is associated with poor disease prognosis in epithelial ovarian cancer. Bao X; Zhao S; Liu T; Liu Y; Liu Y; Yang X J Histochem Cytochem; 2013 Mar; 61(3):206-17. PubMed ID: 23292799 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]